{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:33:30Z","timestamp":1770676410991,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12031-020-01634-4","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T01:02:37Z","timestamp":1593133357000},"page":"137-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased Levels of IL-34 in Acquired Immune-Mediated Neuropathies"],"prefix":"10.1007","volume":"71","author":[{"given":"Sina","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdokht","family":"Mazdeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-0591","authenticated-orcid":false,"given":"Mohammad","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mahdi","family":"Eftekharian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"1634_CR1","doi-asserted-by":"crossref","unstructured":"Ali ZPM, Ghafouri-Fard S, Komaki A, Mazdeh M, Taheri M, Eftekharian MM (2020a) Assessment of IL-38 levels in patients with acquired immune-mediated polyneuropathies. J Molec Neurosci:1\u20134","DOI":"10.1007\/s12031-020-01558-z"},{"key":"1634_CR2","doi-asserted-by":"crossref","unstructured":"Ali ZPM, Taheri M, Sangsefidi S, Arsang-Jang S, Mazdeh M, Zamani A, Ghafouri-Fard S, Eftekharian MM (2020b) Evaluation of expression of STAT genes in immune-mediated polyneuropathies. J Molec Neurosci:1\u20138","DOI":"10.1007\/s12031-020-01494-y"},{"key":"1634_CR3","unstructured":"Arnold, M. (n.d.) AIDP\/CIDP Part 1: Evaluation and Diagnosis"},{"key":"1634_CR4","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1172\/JCI81227","volume":"125","author":"S B\u00e9zie","year":"2015","unstructured":"B\u00e9zie S, Picarda E, Ossart J, Tesson L, Usal C, Renaudin K, Anegon I, Guillonneau C (2015) IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest 125:3952\u20133964","journal-title":"J Clin Invest"},{"key":"1634_CR5","doi-asserted-by":"crossref","unstructured":"Bostr\u00f6m EA, Lundberg P (2013) The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation. PloS One 8","DOI":"10.1371\/journal.pone.0081665"},{"key":"1634_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-18433-4","volume":"8","author":"S Boulakirba","year":"2018","unstructured":"Boulakirba S, Pfeifer A, Mhaidly R, Obba S, Goulard M, Schmitt T, Chaintreuil P, Calleja A, Furstoss N, Orange F (2018) IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential. Sci Rep 8:1\u201311","journal-title":"Sci Rep"},{"key":"1634_CR7","doi-asserted-by":"crossref","unstructured":"Chen, H., Ende, N. & Souayah, N. 2012. The cytokine profile of chronic inflammatory demyelinating polyneuropathy (P06. 134) AAN Enterprises","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P06.134"},{"key":"1634_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1529-8027.2010.00294.x","volume":"15","author":"LJ Chi","year":"2010","unstructured":"Chi LJ, Xu WH, Zhang ZW, Huang HT, Zhang LM, Zhou J (2010) Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 15:345\u2013356","journal-title":"J Peripher Nerv Syst"},{"key":"1634_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/rheumatology\/kes435","volume":"52","author":"F Ciccia","year":"2013","unstructured":"Ciccia F, Alessandro R, Rodolico V, Guggino G, Raimondo S, Guarnotta C, Giardina A, Sireci G, Campisi G, DE Leo G (2013) IL-34 is overexpressed in the inflamed salivary glands of patients with Sj\u00f6gren\u2019s syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes. Rheumatology 52:1009\u20131017","journal-title":"Rheumatology"},{"key":"1634_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jbspin.2013.04.014","volume":"80","author":"G Clavel","year":"2013","unstructured":"Clavel G, Thiolat A, Boissier M-C (2013) Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38. Joint Bone Spine 80:449\u2013453","journal-title":"Joint Bone Spine"},{"key":"1634_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jneuroim.2018.08.001","volume":"323","author":"M Debnath","year":"2018","unstructured":"Debnath M, Nagappa M, Subbanna M, Sundaravadivel P, Talukdar PM, Shivakumar V, Wahatule R, Dutta D, Binukumar B, Sinha S (2018) Th17 pathway signatures in a large Indian cohort of Guillain Barre syndrome. J Neuroimmunol 323:125\u2013130","journal-title":"J Neuroimmunol"},{"key":"1634_CR12","volume-title":"Electrodiagnostic medicine","author":"D Dumitru","year":"2002","unstructured":"Dumitru, D., Amato, A. A. & Zwarts, M. J. 2002. Electrodiagnostic medicine, Hanley & Belfus Philadelphia"},{"key":"1634_CR13","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00296-010-1688-7","volume":"31","author":"H Eda","year":"2011","unstructured":"Eda H, Shimada H, Beidler DR, Monahan JB (2011) Proinflammatory cytokines, IL-1\u03b2 and TNF-\u03b1, induce expression of interleukin-34 mRNA via JNK-and p44\/42 MAPK-NF-\u03baB pathway but not p38 pathway in osteoblasts. Rheumatol Int 31:1525\u20131530","journal-title":"Rheumatol Int"},{"key":"1634_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1042\/CS20150132","volume":"129","author":"E Franz\u00e8","year":"2015","unstructured":"Franz\u00e8 E, Monteleone I, Cupi ML, Mancia P, Caprioli F, Marafini I, Colantoni A, Ortenzi A, Laudisi F, Sica G (2015) Interleukin-34 sustains inflammatory pathways in the gut. Clin Sci 129:271\u2013280","journal-title":"Clin Sci"},{"key":"1634_CR15","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.7150\/ijbs.35070","volume":"15","author":"Y Ge","year":"2019","unstructured":"Ge Y, Huang M, Yao Y-M (2019) Immunomodulation of Interleukin-34 and its potential significance as a disease biomarker and therapeutic target. Int J Biol Sci 15:1835","journal-title":"Int J Biol Sci"},{"key":"1634_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMra041347","volume":"352","author":"H K\u00f6ller","year":"2005","unstructured":"K\u00f6ller H, Kieseier BC, Jander S, Hartung H-P (2005) Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 352:1343\u20131356","journal-title":"N Engl J Med"},{"key":"1634_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.1154370","volume":"320","author":"H Lin","year":"2008","unstructured":"Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E, Halenbeck R, Wu G, Zhou A, Behrens D (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320:807\u2013811","journal-title":"Science"},{"key":"1634_CR18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/humrep\/dey037","volume":"33","author":"R Lindau","year":"2018","unstructured":"Lindau R, Mehta RB, Lash G, Papapavlou G, Boij R, Berg G, Jenmalm M, Ernerudh J, Svensson-Arvelund J (2018) Interleukin-34 is present at the fetal\u2013maternal interface and induces immunoregulatory macrophages of a decidual phenotype in vitro. Hum Reprod 33:588\u2013599","journal-title":"Hum Reprod"},{"key":"1634_CR19","doi-asserted-by":"publisher","first-page":"21972","DOI":"10.1074\/jbc.M112.442731","volume":"288","author":"S Nandi","year":"2013","unstructured":"Nandi S, Cioce M, Yeung Y-G, Nieves E, Tesfa L, Lin H, Hsu AW, Halenbeck R, Cheng H-Y, Gokhan S (2013) Receptor-type protein-tyrosine phosphatase \u03b6 is a functional receptor for interleukin-34. J Biol Chem 288:21972\u201321986","journal-title":"J Biol Chem"},{"key":"1634_CR20","doi-asserted-by":"publisher","first-page":"758639","DOI":"10.1155\/2014\/758639","volume":"2014","author":"KK Nyati","year":"2014","unstructured":"Nyati KK, Prasad KN (2014) Role of cytokines and toll-like receptors in the immunopathogenesis of Guillain-Barr\u00e9 syndrome. Mediat Inflamm 2014:758639\u2013758639","journal-title":"Mediat Inflamm"},{"key":"1634_CR21","doi-asserted-by":"crossref","unstructured":"Sangsefidi S, Ghafouri-Fard S, Komaki A, Mazdeh M, Taheri M, Eftekharian MM (2020) High levels of Il-19 in patients with chronic inflammatory demyelinating polyneuropathy. J Mol Neurosci","DOI":"10.1007\/s12031-020-01602-y"},{"key":"1634_CR22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.bbamcr.2015.01.023","volume":"1853","author":"AI Segaliny","year":"2015","unstructured":"Segaliny AI, Brion R, Mortier E, Maillasson M, Ch\u00e9rel M, Jacques Y, Le Goff B, Heymann D (2015) Syndecan-1 regulates the biological activities of interleukin-34. Biochim Biophys Acta (BBA)-Molec Cell Res 1853:1010\u20131021","journal-title":"Biochim Biophys Acta (BBA)-Molec Cell Res"},{"key":"1634_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0022-510X(96)00319-X","volume":"147","author":"S Sivieri","year":"1997","unstructured":"Sivieri S, Ferrarini A, Lolli F, Mat\u00e0 S, Pinto F, Tavolato B, Gallo P (1997) Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. J Neurol Sci 147:93\u201395","journal-title":"J Neurol Sci"},{"key":"1634_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1089\/jir.2012.0122","volume":"33","author":"Y Tian","year":"2013","unstructured":"Tian Y, Shen H, Xia L, Lu J (2013) Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production. J Interf Cytokine Res 33:398\u2013401","journal-title":"J Interf Cytokine Res"},{"key":"1634_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000052111","volume":"45","author":"FG van der Meche","year":"2001","unstructured":"van der Meche FG, van Doorn PA, Meulstee J, Jennekens FG (2001) Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol 45:133\u2013139","journal-title":"Eur Neurol"},{"key":"1634_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fnagi.2017.00244","volume":"9","author":"DG Walker","year":"2017","unstructured":"Walker DG, Tang TM, Lue L-F (2017) Studies on colony stimulating factor receptor-1 and ligands colony stimulating factor-1 and interleukin-34 in Alzheimer\u2019s disease brains and human microglia. Front Aging Neurosci 9:244","journal-title":"Front Aging Neurosci"},{"key":"1634_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ni.2360","volume":"13","author":"Y Wang","year":"2012","unstructured":"Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, Barrow AD, Diamond MS, Colonna M (2012) IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 13:753\u2013760","journal-title":"Nat Immunol"},{"key":"1634_CR28","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung H-P (2012) Guillain\u2013Barr\u00e9 syndrome. N Engl J Med 366:2294\u20132304","journal-title":"N Engl J Med"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01634-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01634-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:29:45Z","timestamp":1624663785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01634-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01634-4","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by ethical committee of Hamadan University of Medical Sciences (IR.UMSHA.REC.1397.948).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}